Skip to main content

Table 2 Baseline demographic and clinical variables of the two groups enrolled in the study

From: Effects of a sensory-motor orthotic on postural instability rehabilitation in Parkinson’s disease: a pilot study

  EXP Group CTRL Group Statistics
mean ± SD mean ± SD Baseline
Gender (M/F) 7/3 5/3  
Age (yr) 69.18 ± 7.61 63.37 ± 6.89 p = 0.24
Height (cm) 160.91 ± 9.58 160.62 ± 14.74 p = 0.96
Weight (kg) 69.54 ± 13.33 67.62 ± 8.31 p = 0.72
Disease duration (yr) 7.82 ± 4.00 8.12 ± 2.90 p = 0.86
Falls (n) 1.45 ± 2.16 0.87 ± 0.99 p = 0.07
Levodopa (mg/day) 455.32 ± 355.49 409.19 ± 340.68 p = 0.74
Dopamine agonist (LEDD mg)
Pramipexole E.R. n = 2 n = 3 N.A.
Ropirinole E.R. n = 3 n = 3 N.A.
Rotigotine (n = 1) n = 1 n = 1 N.A.
Rasagiline (n = 1) n = 2 n = 1 N.A.
Other drugs (LEDD mg)
Entacapone n = 1 n = 2 N.A.
Selegiline n = 1 n = 2 N.A.
Amantadine n = 2 n = 2 N.A.
  1. Exp, Experimental; CTRL, Control; M, Male; F, Female; Yr, Years; Cm, centimeters; Kg, Kilograms; Mg = Milligrams; N, number; ER = Extended Released; N.A., Not Applicable